ICD9 Online Home

Free online searchable
2009 ICD-9-CM

Search for  

Diseases and Injuries
>> Tabular Index
>> Alphabetic Index

>> Tabular Index
>> Alphabetic Index

>> Drugs / Chemicals
>> External Causes

Other Resources
>> HCPCS Alpha
>> Medical Dictionary
>> Drug Directory


V07.5 Prophylactic use of agents affecting estrogen receptors and estrogen levels
Code first, if applicable:
malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
malignant neoplasm of prostate (185)
Use additional code, if applicable, to identify:
estrogen receptor positive status (V86.0)
family history of breast cancer (V16.3)
genetic susceptibility to cancer (V84.01-V84.09)
personal history of breast cancer (V10.3)
personal history of prostate cancer (V10.46)
postmenopausal status (V49.81)
hormone replacement therapy (postmenopausal) (V07.4)
V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs)
Prophylactic use of:
raloxifene (Evista)
tamoxifen (Nolvadex)
toremifene (Fareston)
V07.52 Prophylactic use of aromatase inhibitors
Prophylactic use of:
anastrozole (Arimidex)
exemestar (Aromasin)
letrozole (Femara)
V07.59 Prophylactic use of other agents affecting estrogen receptors and estrogen levels
Prophylactic use of:
estrogen receptor downregulators
fulvestrant (Faslodex)
gonadotropin-releasing hormone (GnRH) agonist
goserelin acetate (Zoladex)
leuprolide acetate (leuprorelin) (Lupron)
megestrol acetate (Megace)
Web icd9cm.chrisendres.com